Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

Abstract Background Bedaquiline was recently introduced into World Health Organization (WHO)-recommended regimens for treatment of drug resistant tuberculosis. There is limited data on the long-term safety of bedaquiline. Because bedaquiline prolongs the QT interval, there are concerns regarding car...

Full description

Bibliographic Details
Main Authors: Jackie Jones, Vanessa Mudaly, Jacqueline Voget, Tracey Naledi, Gary Maartens, Karen Cohen
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Infectious Diseases
Subjects:
Drug-resistant TB
Pharmacovigilance
Drug safety
Bedaquiline
Online Access:http://link.springer.com/article/10.1186/s12879-019-4197-7

Internet

http://link.springer.com/article/10.1186/s12879-019-4197-7

Similar Items